Lakewood-Amedex Biotherapeutics (LABT)
Nasdaq Market Open
Lakewood-Amedex Biotherapeutics Inc. is a clinical-stage biotechnology company focused on new treatments for bacterial infections. Its work centres on Bisphosphocins, a proprietary class of antimicrobial compounds designed to act quickly and address a broad range of bacterial pathogens, including strains that have become resistant to commonly used antibiotics.
The company’s lead programme is Nu-3, a topical antimicrobial gel being evaluated for mildly infected diabetic foot ulcers. Diabetic foot infections are a serious complication of diabetes and can be difficult to treat because wounds may heal slowly and are vulnerable to resistant bacteria. By delivering the therapy directly to the infected area, Lakewood-Amedex aims to provide a targeted approach for a condition with meaningful medical need.
Beyond Nu-3, the company is developing additional candidates from the Bisphosphocin platform. Its early-stage pipeline includes potential treatments for complicated urinary tract infections and pulmonary infections, both of which represent large areas of concern for hospitals, physicians and public health systems due to the spread of antimicrobial resistance.
Lakewood-Amedex remains at the development stage, so its value is closely linked to clinical trial progress, regulatory outcomes and the ability to demonstrate safety and efficacy in defined infection settings. The company is positioned within the wider biotechnology effort to replenish the antibiotic pipeline, an area that has become increasingly important as pathogens such as MRSA and VRE limit the effectiveness of existing therapies.
Last updated
- Market Cap
- $4,376,643
- P/E
- —
- P/FCF
- —
- P/S
- —
- Enterprise Value
- —
- Sector
- Materials
- Industry
- Pharmaceutical Preparations
- Address
- 8031 COOPER CREEK BLVD., UNIVERSITY PARK, FL, 34201
No recent news is linked to this listing.
- Market Cap
Market cap is the total value of a company's shares, calculated by multiplying the stock price by the number of shares outstanding.
- $4,376,643
- Enterprise Value
Enterprise value is the total value of a company, including its market cap, debt, and cash.
- —
- P/E
P/E ratio compares a company's share price to its earnings per share.
- —
- P/B
P/B ratio compares a company's share price to its book value per share.
- —
- P/S
P/S ratio compares a company's share price to its revenue per share.
- —
- EV / EBITDA
EV/EBITDA measures a company's value compared to its earnings before interest, taxes, depreciation, and amortization.
- —
- EV / Sales
EV/Sales measures a company's value compared to its total revenue.
- —
- EPS
- —
- Dividend Yield
Dividend yield shows how much a company pays in dividends each year compared to its share price.
- —
- P/FCF
Price-to-free-cash-flow ratio compares a company's share price to the cash it generates after expenses and investments.
- —
- P/CF
P/CF ratio compares a company's share price to the cash flow it generates from its operations.
- —
- Free Cash Flow
Free cash flow is the cash a company has left after covering operating costs and capital expenses.
- —
- ROE
ROE measures how effectively a company uses shareholders' equity to generate profit.
- —
- ROA
ROA measures how effectively a company uses its assets to generate profit.
- —
- Debt / Equity
Debt-to-equity ratio compares a company's total debt to its shareholders' equity.
- —
- Current Ratio
Current ratio measures a company's ability to pay short-term debts using its short-term assets.
- —
- Quick Ratio
Quick ratio measures a company's ability to pay short-term debts using cash and other easily available assets.
- —
- Cash
Cash ratio measures a company's ability to cover short-term debts using only cash and cash equivalents.
- —
- Avg Volume
Average volume shows the average number of shares traded over the last 30 trading days, helping indicate liquidity.
- —
- Fundamentals Snapshot Price
Fundamentals snapshot price is the stock price used when calculating the company's financial ratios and metrics.
- —
Financial statements are not available for this listing.
| Kind | Filing | Date | Link |
|---|---|---|---|
| edgar index | 8-K — Lakewood-Amedex Biotherapeutics Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | SCHEDULE 13G — Lakewood-Amedex Biotherapeutics Inc. | View Filing | |
| edgar index | 424B3 — Lakewood-Amedex Biotherapeutics Inc. | View Filing | |
| edgar index | 424B3 — Lakewood-Amedex Biotherapeutics Inc. | View Filing | |
| edgar index | 8-K — Lakewood-Amedex Biotherapeutics Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 424B3 — Lakewood-Amedex Biotherapeutics Inc. | View Filing | |
| edgar index | 424B3 — Lakewood-Amedex Biotherapeutics Inc. | View Filing | |
| edgar index | 10-Q — Lakewood-Amedex Biotherapeutics Inc. | View Filing | |
| edgar index | 424B4 — Lakewood-Amedex Biotherapeutics Inc. | View Filing | |
| edgar index | EFFECT — Lakewood-Amedex Biotherapeutics Inc. | View Filing | |
| edgar index | CORRESP — Lakewood-Amedex Biotherapeutics Inc. | View Filing | |
| edgar index | UPLOAD — Lakewood-Amedex Biotherapeutics Inc. | View Filing | |
| edgar index | 3 — Lakewood-Amedex Biotherapeutics Inc. | View Filing | |
| edgar index | 4 — Lakewood-Amedex Biotherapeutics Inc. | View Filing | |
| form 3 | Form 3 — Tucker Joseph Edward | View Filing | |
| edgar index | S-1 — Lakewood-Amedex Biotherapeutics Inc. | View Filing | |
| edgar index | 3 — Lakewood-Amedex Biotherapeutics Inc. | View Filing | |
| edgar index | 3 — Lakewood-Amedex Biotherapeutics Inc. | View Filing | |
| edgar index | 3 — Lakewood-Amedex Biotherapeutics Inc. | View Filing | |
| edgar index | 3 — Lakewood-Amedex Biotherapeutics Inc. | View Filing | |
| form 3 | Form 3 — Ceccacci Peter | View Filing | |
| form 3 | Form 3 — Ceccacci Peter | View Filing | |
| form 3 | Form 3 — Ceccacci Peter | View Filing | |
| form 3 | Form 3 — Ceccacci Peter | View Filing | |
| form 3 | Form 3 — Ceccacci Peter | View Filing | |
| form 3 | Form 3 — Ceccacci Peter | View Filing | |
| form 3 | Form 3 — Cooper Kelvin | View Filing | |
| form 3 | Form 3 — Cooper Kelvin | View Filing | |
| form 3 | Form 3 — Cooper Kelvin | View Filing | |
| form 3 | Form 3 — Cooper Kelvin | View Filing | |
| form 3 | Form 3 — Cooper Kelvin | View Filing | |
| form 3 | Form 3 — Cooper Kelvin | View Filing | |
| form 3 | Form 3 — Balzer Thomas | View Filing | |
| form 3 | Form 3 — Balzer Thomas | View Filing | |
| form 3 | Form 3 — Balzer Thomas | View Filing | |
| form 3 | Form 3 — Balzer Thomas | View Filing | |
| form 3 | Form 3 — Balzer Thomas | View Filing | |
| form 3 | Form 3 — DeRoma Leonard James | View Filing | |
| form 3 | Form 3 — DeRoma Leonard James | View Filing | |
| form 3 | Form 3 — DeRoma Leonard James | View Filing | |
| form 3 | Form 3 — DeRoma Leonard James | View Filing | |
| form 3 | Form 3 — DeRoma Leonard James | View Filing | |
| form 3 | Form 3 — DeRoma Leonard James | View Filing | |
| form 3 | Form 3 — DeRoma Leonard James | View Filing | |
| edgar index | 424B3 — Lakewood-Amedex Biotherapeutics Inc. | View Filing | |
| edgar index | 8-K — Lakewood-Amedex Biotherapeutics Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| form 4 | Form 4 — Tucker Joseph Edward | View Filing | |
| edgar index | 424B4 — Lakewood-Amedex Biotherapeutics Inc. | View Filing | |
| edgar index | CERT — Lakewood-Amedex Biotherapeutics Inc. | View Filing | |
| edgar index | 8-A12B — Lakewood-Amedex Biotherapeutics Inc. | View Filing | |
| edgar index | EFFECT — Lakewood-Amedex Biotherapeutics Inc. | View Filing | |
| edgar index | S-1/A — Lakewood-Amedex Biotherapeutics Inc. | View Filing | |
| edgar index | S-1/A — Lakewood-Amedex Biotherapeutics Inc. | View Filing | |
| edgar index | S-1/A — Lakewood-Amedex Biotherapeutics Inc. | View Filing | |
| edgar index | S-1/A — Lakewood-Amedex Biotherapeutics Inc. | View Filing | |
| edgar index | S-1/A — Lakewood-Amedex Biotherapeutics Inc. | View Filing | |
| edgar index | S-1 — Lakewood-Amedex Biotherapeutics Inc. | View Filing | |
| edgar index | DRS/A — Lakewood-Amedex Biotherapeutics Inc. | View Filing | |
| edgar index | DRS — Lakewood-Amedex Biotherapeutics Inc. | View Filing |
- Trusted by 1M+ investors
- Global coverage
- Real-time market data
- Independent & unbiased
Join thousands making smarter investment decisions.
Get started for free